Energy stress-activated AMPK phosphorylates Snail1 and suppresses its stability and oncogenic function

Mei Li1, Litao Zhang2, Tangming Guan1

  • 1State Key Laboratory of Bioactive Molecules and Druggability Assessment/International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Ministry of Education (MOE) of China/College of Pharmacy, Jinan University, Guangzhou, 510632, China.

Cancer Letters
|May 30, 2024
PubMed

Insights

AMP-activated protein kinase (AMPK) activation suppresses triple-negative breast cancer (TNBC) progression by targeting Snail1 degradation. This discovery offers a potential new therapeutic strategy for TNBC management.

Area of Science:

  • Molecular oncology
  • Cancer metabolism
  • Signal transduction

Background:

  • Triple-negative breast cancer (TNBC) is aggressive with limited treatment options.
  • Aberrant cancer metabolism influences tumor progression and therapeutic resistance.
  • The role of glucose metabolism in TNBC progression requires further elucidation.

Purpose of the Study:

  • To investigate the role of aberrant glucose metabolism in regulating Snail1 turnover in TNBC.
  • To identify the mechanisms linking glucose metabolism to Snail1-mediated TNBC progression.
  • To explore the therapeutic potential of targeting this pathway in TNBC.

Main Methods:

  • Investigated the effect of glucose deprivation on Snail1 regulation.
  • Utilized biochemical assays to determine AMP-activated protein kinase (AMPK) phosphorylation of Snail1.
  • Assessed the impact of Snail1 phosphorylation on its interaction with FBXO11 and subsequent degradation.
  • Performed in vitro and in vivo experiments to evaluate the functional consequences of this pathway.
  • Conducted histological analyses of TNBC specimens to correlate p-AMPKα and Snail1 levels.

Main Results:

  • Glucose deprivation activates AMPK, leading to direct phosphorylation of Snail1 at Ser11.
  • Phosphorylated Snail1 is recruited by the E3 ligase FBXO11, promoting its degradation.
  • Suppression of Snail1 by AMPK activation reduces stemness, metastasis, and chemo-resistance in TNBC.
  • Clinical data show an inverse correlation between p-AMPKα and Snail1 in TNBC tissues.

Conclusions:

  • AMPK activation links glucose metabolism to Snail1 degradation, suppressing TNBC stemness, metastasis, and chemo-resistance.
  • This study reveals a novel mechanism regulating Snail1 turnover.
  • AMPK agonists represent a promising therapeutic strategy for TNBC management.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.4K